Inspire Medical Systems Inc (INSP)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.77B
Last updated: Nov 17, 2026 at 11:06 AM ET
Inspire Medical Systems Inc (INSP) P/E Ratio & Valuation History
Inspire Medical Systems (INSP) trades at 29.1x trailing earnings and 1.9x sales. Its P/S of 1.9x is below its 5-year median of 7.7x. Its forward P/E is 51.5x. The median P/E across 6 similar companies is 27.0x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 43.5% lower over the next year. Its free cash flow yield is 5.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 29.1x |
| Forward P/E | 51.5x |
| Price to sales | 1.9x |
| Price to book | 2.1x |
| EV/EBITDA | 46.1x |
| Price to FCF | 17.5x |
| EV/FCF | 15.5x |
| PEG | N/A |
| FCF yield | 5.7% |
Historical Medians
Against its 10-year medians, its P/S is 87.3% below 15.0x and its P/B is 80.2% below 10.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.9x | 7.7x | 15.0x |
| P/B | 2.1x | 8.5x | 10.6x |
Valuation History
Over the 8 year ends shown, its P/S ranged from 3.0x in 2025 to 42.9x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $92.23 | 35.7x | 3.0x | 3.4x |
| 2024 | $185.38 | 107.2x | 6.9x | 8.3x |
| 2023 | $203.43 | N/A | 9.6x | 10.7x |
| 2022 | $251.88 | N/A | 17.7x | 15.3x |
| 2021 | $230.06 | N/A | 26.9x | 27.5x |
| 2020 | $188.09 | N/A | 42.9x | 22.1x |
| 2019 | $74.21 | N/A | 21.6x | 12.8x |
| 2018 | $42.25 | N/A | 4.2x | 5.6x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INSP
What is INSP's forward P/E ratio?
Inspire Medical Systems has a forward P/E ratio of 51.5x.
Is INSP stock overvalued?
GNG's valuation label for INSP is Undervalued. Its P/E of 29.1x compares with a median of 27.0x across 6 similar companies.
What is INSP's price to sales ratio?
Inspire Medical Systems has a price to sales ratio of 1.9x.
INSP pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts